Could the cytological evaluation of pericardial effusions illuminate our path?

Basit Öğe Kaydı
dc.contributor.authorEkmekçi, Cenk
dc.contributor.authorEkmekçi, Sümeyye
dc.contributor.authorDere, Yelda
dc.contributor.authorAdalı, Yasemen
dc.contributor.authorEkinci, Selim
dc.contributor.authorÇabuk, Ali Kemal
dc.contributor.authorÖksüz, Pınar
dc.date.accessioned2025-01-27T19:36:57Z
dc.date.available2025-01-27T19:36:57Z
dc.date.issued2018
dc.departmentÇanakkale Onsekiz Mart Üniversitesi
dc.description.abstractObjective: Pericardial effusion (PE) is a common clinical condition that can develop as aresult of systemic or heart disease. In our study, we synthesized the cytopathological andclinical results of patients who underwent pericardiocentesis due to pericardial effusion.Method: A total of 213 patients who underwent percutaneous pericardiocentesis between2007-2017 were included in the study: their cytologic and histopathologic diagnoses werenoted and their relations were examined.Results: Hundred and thirty-two cases were male (61.9%), 81 were female (38.1%) and themean of the study population age was 59.9 (min 13-max 97) years. Hundred and sixty-eightpatients had benign (78.9%), 10 suspicious (4.6%), 3 non-diagnostic (1.4%) and 32 malignant cytologies (15.1%). Benign pericardial effusion was the most common diagnosis.Malignant cytology findings were interpreted as lung carcinoma (n=20: 62.5%), rhabdomyosarcoma (n=1: 3.1%), poorly differentiated adenocarcinoma (n=2: 6.2%), a gastrointestinal system carcinoma (n=4: 12.5%), undifferentiated epithelial tumor (n=1: 3.1%),breast carcinoma (n=1: 3.1%), and unspecified malignant tumor (n=3: 9%). Four (2.4%)of the 168 patients having diagnosis of benign cytology had previously received diagnosis ofa malignant disease, however examination of cytological specimen. Did not reveal anymalignancy. Three (30%) of the 10 patients with suspicious cytology, had received diagnosis of a malignant disease previously.Conclusion: In developed countries, it is reported that more than 50% of the PE’s areidiopathic. The percentage of cancer-associated PE’s is 10-25%. In our study, 78.9% ofour cases had a benign diagnosis, and 15.1% had malignant PE consistent with the literature findings. Cytological sampling in pericardial fluid is a method that can shed light onthe diagnosis of many diseases.
dc.identifier.doi10.5222/terh.2018.099
dc.identifier.endpage103
dc.identifier.issn1305-7073
dc.identifier.issn1305-7146
dc.identifier.issue2
dc.identifier.startpage99
dc.identifier.trdizinid319651
dc.identifier.urihttps://doi.org/10.5222/terh.2018.099
dc.identifier.urihttps://search.trdizin.gov.tr/tr/yayin/detay/319651
dc.identifier.urihttps://hdl.handle.net/20.500.12428/17063
dc.identifier.volume28
dc.indekslendigikaynakTR-Dizin
dc.language.isoen
dc.relation.ispartofİzmir Tepecik Eğitim Hastanesi Dergisi
dc.relation.publicationcategoryMakale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_TRD_20250125
dc.subjectGenel ve Dahili Tıp
dc.subjectPatoloji
dc.subjectSağlık Bilimleri ve Hizmetleri
dc.subjectKalp ve Kalp Damar Sistemi
dc.subjectTıbbi Laboratuar Teknolojisi
dc.titleCould the cytological evaluation of pericardial effusions illuminate our path?
dc.typeArticle

Dosyalar

Koleksiyon

TR-Dizin İndeksli Yayınlar Koleksiyonu